ClariTrial | Search Clinical Trials

Explore/Cancer

Status

Phase

144,291 results for “Cancer”

Page 1 of 9620

UNKNOWN

Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients

N/ALymphoma, Large B-Cell, Diffuse

Early interim FDG PET/CT after 1 cycle of R-CHOP

The Catholic University of Korea53 participants1 site · South KoreaCompletes Nov 2017

Compare CT.gov Full analysis →

Not Yet Recruiting

Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer

N/AMuscle Invasive Bladder Cancer

RadiochemotherapyRadical cystectomy

Brazilian Clinical Research Institute336 participants1 site · BrazilCompletes Dec 2031

Compare CT.gov Full analysis →

Completed

Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women

N/AHIV Infections

surgical management of high grade lesions

French National Agency for Research on AIDS and Viral Hepatitis676 participantsCompletes Nov 2012

Compare CT.gov Full analysis →

Completed

Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting

Phase 2Ovarian Cancer

Niraparib

The University of Hong Kong20 participants1 site · Hong KongCompletes Oct 2023

Compare CT.gov Full analysis →

Completed

Results posted

RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Phase 3Primary Biliary Cholangitis

Seladelpar 10 mgPlaceboSeladelpar 5 mg

Gilead Sciences193 participants134 sites · United States, Argentina, AustraliaCompletes Aug 2023

Compare CT.gov Full analysis →

UNKNOWN

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

Phase 2Phase 3Prostate CancerCastrate Resistant Prostate Cancer

Enzalutamide 40 MGDocetaxel injection

Zhongnan Hospital120 participants2 sites · ChinaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

Phase 2Leukemia

PirtobrutinibObinutuzumabVenetoclax+2 more

M.D. Anderson Cancer Center60 participants1 site · United StatesCompletes Apr 2028

Compare CT.gov Full analysis →

Completed

Results posted

Cantharidin and Occlusion in Verruca Epithelium

Phase 2Common WartWarts HandWarts

VP-102 Cantharidin topical film forming solutionVP-102 Cantharidin, topical film forming solution

Verrica Pharmaceuticals Inc.56 participants5 sites · United StatesCompletes May 2019

Compare CT.gov Full analysis →

Active

A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer

Phase 3Early or Locally Advanced HER2-positive Breast Cancer

KN026HB1801Pertuzumab+3 more

Shanghai JMT-Bio Inc.520 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Completed

Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants

Phase 1Cytomegalovirus Infections

CMV-Peptide-Specific T cells

Memorial Sloan Kettering Cancer Center30 participants1 site · United StatesCompletes Mar 2014

Compare CT.gov Full analysis →

Completed

Results posted

Navigation for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC

N/ASquamous Cell Carcinoma of Head and Neck

NDURE

Medical University of South Carolina18 participants1 site · United StatesCompletes Apr 2020

Compare CT.gov Full analysis →

Active

Phase II RCT of an Internet-adaptation of Managing Cancer and Living Meaningfully (iCALM)

N/AAdvanced Cancer

Internet Adaptation of Managing Cancer and Living Meaningfully (iCALM)

University Health Network, Toronto50 participants1 site · CanadaCompletes Dec 2025

Compare CT.gov Full analysis →

Completed

Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions

N/APotentially Malignant LesionsOral Lichen PlanusLeukoplakia, Oral

Real-time Polymerase Chain Reaction technique

Fayoum University45 participants1 site · EgyptCompletes Dec 2022

Compare CT.gov Full analysis →

Terminated

Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer

Phase 3Colorectal Cancer

Imprime PGG + cetuximabCetuximab

HiberCell, Inc.217 participants53 sites · United States, France, GermanyCompletes Feb 2017

Compare CT.gov Full analysis →

UNKNOWN

Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma

Phase 3Ameloblastoma

Dabrafenib

Shandong University10 participantsCompletes Nov 2025

Compare CT.gov Full analysis →

1–15 of 144,291

Explore/Cancer

Status

Phase

144,291 results for “Cancer”

Page 1 of 9620

UNKNOWN

Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients

N/ALymphoma, Large B-Cell, Diffuse

Early interim FDG PET/CT after 1 cycle of R-CHOP

The Catholic University of Korea53 participants1 site · South KoreaCompletes Nov 2017

Compare CT.gov Full analysis →

Not Yet Recruiting

Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer

N/AMuscle Invasive Bladder Cancer

RadiochemotherapyRadical cystectomy

Brazilian Clinical Research Institute336 participants1 site · BrazilCompletes Dec 2031

Compare CT.gov Full analysis →

Completed

Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women

N/AHIV Infections

surgical management of high grade lesions

French National Agency for Research on AIDS and Viral Hepatitis676 participantsCompletes Nov 2012

Compare CT.gov Full analysis →

Completed

Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting

Phase 2Ovarian Cancer

Niraparib

The University of Hong Kong20 participants1 site · Hong KongCompletes Oct 2023

Compare CT.gov Full analysis →

Completed

Results posted

RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Phase 3Primary Biliary Cholangitis

Seladelpar 10 mgPlaceboSeladelpar 5 mg

Gilead Sciences193 participants134 sites · United States, Argentina, AustraliaCompletes Aug 2023

Compare CT.gov Full analysis →

UNKNOWN

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

Phase 2Phase 3Prostate CancerCastrate Resistant Prostate Cancer

Enzalutamide 40 MGDocetaxel injection

Zhongnan Hospital120 participants2 sites · ChinaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

Phase 2Leukemia

PirtobrutinibObinutuzumabVenetoclax+2 more

M.D. Anderson Cancer Center60 participants1 site · United StatesCompletes Apr 2028

Compare CT.gov Full analysis →

Completed

Results posted

Cantharidin and Occlusion in Verruca Epithelium

Phase 2Common WartWarts HandWarts

VP-102 Cantharidin topical film forming solutionVP-102 Cantharidin, topical film forming solution

Verrica Pharmaceuticals Inc.56 participants5 sites · United StatesCompletes May 2019

Compare CT.gov Full analysis →

Active

A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer

Phase 3Early or Locally Advanced HER2-positive Breast Cancer

KN026HB1801Pertuzumab+3 more

Shanghai JMT-Bio Inc.520 participants1 site · ChinaCompletes Dec 2026

Compare CT.gov Full analysis →

Completed

Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants

Phase 1Cytomegalovirus Infections

CMV-Peptide-Specific T cells

Memorial Sloan Kettering Cancer Center30 participants1 site · United StatesCompletes Mar 2014

Compare CT.gov Full analysis →

Completed

Results posted

Navigation for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC

N/ASquamous Cell Carcinoma of Head and Neck

NDURE

Medical University of South Carolina18 participants1 site · United StatesCompletes Apr 2020

Compare CT.gov Full analysis →

Active

Phase II RCT of an Internet-adaptation of Managing Cancer and Living Meaningfully (iCALM)

N/AAdvanced Cancer

Internet Adaptation of Managing Cancer and Living Meaningfully (iCALM)

University Health Network, Toronto50 participants1 site · CanadaCompletes Dec 2025

Compare CT.gov Full analysis →

Completed

Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions

N/APotentially Malignant LesionsOral Lichen PlanusLeukoplakia, Oral

Real-time Polymerase Chain Reaction technique

Fayoum University45 participants1 site · EgyptCompletes Dec 2022

Compare CT.gov Full analysis →

Terminated

Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer

Phase 3Colorectal Cancer

Imprime PGG + cetuximabCetuximab

HiberCell, Inc.217 participants53 sites · United States, France, GermanyCompletes Feb 2017

Compare CT.gov Full analysis →

UNKNOWN

Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma

Phase 3Ameloblastoma

Dabrafenib

Shandong University10 participantsCompletes Nov 2025

Compare CT.gov Full analysis →

1–15 of 144,291